Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2012
11/21/2012CN102198107B Lacidipine dispersible tablets and preparation method thereof
11/21/2012CN102188717B Self-emulsifying doxorubicin nanometer medicament and preparation method thereof
11/21/2012CN102188439B Nanoparticle liposome for releasing different medicines in programmed manner and preparation and use thereof
11/21/2012CN102178810B Chinese medicinal paste film for treating skin ulcer and preparation method thereof
11/21/2012CN102178709B Micropills of corylus heterophylla leaf extract and preparation method thereof
11/21/2012CN102174184B Biodegradable polymer, preparation method thereof and nucleic acid drug delivery carrier
11/21/2012CN102153060B Method for preparing hydroxyapatite nano-structure microspheres
11/21/2012CN102138900B Solid preparation of oxapium iodide liposome
11/21/2012CN102133225B Compound polyethylene glycol electrolyte pulvis and preparation method thereof
11/21/2012CN102091331B Carboxyl mesoporous silica nanoparticle carrier material and preparation method thereof
11/21/2012CN102085183B Asarin lipid nanospheres and method for preparing same
11/21/2012CN102068700B Phenylboronic acid polyethylene glycol gel and application thereof serving as glucose-sensitive material
11/21/2012CN102060991B Amphiphilic prodrug of 7- ethyl-10-hydroxycamptothecin and preparation method thereof
11/21/2012CN102030882B Method for preparing biodegradable polyurethane material with pH responsiveness
11/21/2012CN102028951B RGDfK-modified oridonin polylactic acid medicament-carrying nanoparticles and preparation method thereof
11/21/2012CN102008449B Lansoprazole enteric pellet and preparation method thereof
11/21/2012CN101991845B Duck infectious serositis inactivated vaccine emulsification method
11/21/2012CN101983628B Mezlocillin sodium and sulbactam sodium drug composite microsphere injection
11/21/2012CN101977630B Ophthalmic composition
11/21/2012CN101961311B 5alpha-androstane (alkyl)-3beta,5,6beta-triol injection and preparation method thereof
11/21/2012CN101954087B Fucoidan medicinal carrier and preparation method thereof
11/21/2012CN101921314B Brain-targeting neurotrophic factor fusion polypeptide for preventing and treating Alzheimer's disease and preparation method
11/21/2012CN101914199B Polyester and preparation method thereof
11/21/2012CN101909599B Counter-pressure filtration of proteins
11/21/2012CN101835492B Thermo-kinetic mixing for pharmaceutical applications
11/21/2012CN101822701B Poplar flower sustained release tablet for treating livestock and poultry dysentery and enteritis and preparation method thereof
11/21/2012CN101808667B Medicinal preparation for oral administration
11/21/2012CN101664378B Medical composition of recombinant human serum albumin and interferon alpha fusion protein
11/21/2012CN101657216B Novel base for dry solid dispersion, solid dispersion containing the base, and composition containing the dispersion
11/21/2012CN101648028B Vitamin-targeted imaging agents
11/21/2012CN101637462B Compositions for conjugated estrogens and associated methods
11/21/2012CN101621990B Orally administrable films
11/21/2012CN101606921B Acarbose solid sustained-release preparation and preparing method thereof
11/21/2012CN101588819B Factor ix moiety-polymer conjugates having a releaseable linkage
11/21/2012CN101586137B Method for adding ethanol to enhance beta-cyclodextrin yield
11/21/2012CN101553206B Water insoluble polymer matrix for drug delivery
11/21/2012CN101548978B Pharmaceutical composition containing alendronate sodium
11/21/2012CN101466409B Leptomycin derivatives
11/21/2012CN101365423B Sustained release small molecule drug formulation
11/21/2012CN101239044B 固形组合物 Solid composition
11/21/2012CN101088502B Mixture solution containing conjugate of transferrin and quercetin and use thereof
11/20/2012US8314230 Cyclodextrin-based polymers for therapeutics delivery
11/20/2012US8314156 Compositions and methods of delivery of pharmacological agents
11/20/2012US8314074 Formulations comprising antisense nucleotides to connexins
11/20/2012US8314069 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
11/20/2012US8313771 Phosphazene hydrogels with chemical corss-link, preparation method thereof and use thereof
11/20/2012US8313769 Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
11/20/2012US8313767 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
11/20/2012US8313761 Mesoporous implants for administering substances and methods of producing implants
11/20/2012US8313757 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
11/20/2012US8313754 Ophthalmic compositions containing a synergistic combination of two polymers
11/20/2012US8313738 Pharmaceutical composition for intracellular acidification with cis-urocanic acid
11/20/2012US8313732 Formoterol superfine formulation
11/20/2012US8313731 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors
11/20/2012US8313728 Vitamin-targeted imaging agents
11/20/2012CA2777431A1 Pharmaceutical composition and method for producing the same
11/20/2012CA2649997C Compositions comprising phenylephrine and acetaminophen for treatment of respiratory illness
11/20/2012CA2633171C Antibodies against tumor-associated antigenic target (tat) polypeptides
11/20/2012CA2584406C Lecithinized superoxide dismutase composition and a process for its production
11/20/2012CA2560278C Modified bouganin proteins, cytotoxins and methods and uses thereof
11/20/2012CA2520391C Novel cyclodextrin derivatives, method for the preparation thereof and use thereof for the solubilization of pharmacologically active substances
11/20/2012CA2493839C Breath freshening and oral cleansing product with magnolia bark extract
11/20/2012CA2492989C Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
11/20/2012CA2490735C Liquid preparation comprising oligopeptides and etherified cyclodextrin
11/20/2012CA2486944C Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications
11/20/2012CA2482929C Tuberculin immunoadjuvant
11/20/2012CA2467365C Poxvirus containing formulations and process for preparing stable, poxvirus containing compositions
11/20/2012CA2265915C Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
11/15/2012WO2012155055A2 Integrin-targeted imaging of inflammation in vascular remodeling
11/15/2012WO2012154986A1 Implantable polymeric device for sustained release of sufentanil
11/15/2012WO2012154942A2 Ceramide anionic liposome compositions
11/15/2012WO2012154738A1 Composition and method to improve intestinal health
11/15/2012WO2012154474A2 Biomaterial composite composition and method of use
11/15/2012WO2012154078A1 Antimicrobially active pharmaceutical composition for parenteral use, and method for producing said composition
11/15/2012WO2012154077A1 Pharmaceutical composition for the treatment of tuberculosis and other infections, and method for producing said composition
11/15/2012WO2012154076A1 Antibacterially active pharmaceutical composition for parenteral use, and method for producing said composition
11/15/2012WO2012154018A1 Activated, micronized zeolite, method for activating and micronizing same and use thereof as a carrier in pharmaceutical preparations and dietary supplements
11/15/2012WO2012153827A1 Stable drug composition
11/15/2012WO2012153635A1 Therapeutic muscular dystrophy drug having bubble liposome loaded with morpholino as active ingredient
11/15/2012WO2012153620A1 Drug, functional food, method for stabilizing target protein, fused protein, nucleic acid, and recombinant
11/15/2012WO2012153616A1 Lipid membrane structure capable of imigrating to target cell and method for producing same, and method for screening for substance exhibiting effect thereof in target cell
11/15/2012WO2012153606A1 Composite film
11/15/2012WO2012153576A1 Organic nanotube having hydrophobized inner surface, and encapsulated medicinal agent prepared using the nanotube
11/15/2012WO2012153396A1 Non-aqueous patch
11/15/2012WO2012153339A2 Stevia based sweetening composition
11/15/2012WO2012153297A1 Targeted polymeric conjugates and uses thereof
11/15/2012WO2012153254A1 Pretargeting kit for imaging or therapy comprising a trans - cyclooctene dienophile and a diene
11/15/2012WO2012153193A2 Protein-active agent conjugates and method for preparing the same
11/15/2012WO2012153071A2 Polysaccharides having a variable degree of functionalization
11/15/2012WO2012153070A1 Functionalised oligosaccharides
11/15/2012WO2012152707A1 Microemulsions
11/15/2012WO2012129497A3 Swallowable medication capsule
11/15/2012WO2012128587A3 Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor
11/15/2012WO2012128520A3 Liquid-type composition for treating gastroesophageal reflux disease
11/15/2012WO2012125830A3 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
11/15/2012WO2012125693A3 Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same
11/15/2012WO2012122544A3 Protein nanoparticle dispersions
11/15/2012WO2012089622A3 Topical localized isoxazoline formulation
11/15/2012WO2012079047A9 Targeting kidney mesangium with nanoparticles of defined diameter
11/15/2012WO2012078831A3 Smart polymeric nanoparticles which overcome multidrug resistance to cancer chemotherapeutics and treatment-related systemic toxicity
1 ... 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 ... 1712